Zhejiang Xianju Pharmaceutical Co Ltd (002332) — Financial Flexibility Index
Zhejiang Xianju Pharmaceutical Co Ltd (002332) has a Financial Flexibility Index of 0.13x as of September 2025. Free cash flow of CN¥160.05 Million (operating CF CN¥130.05 Million minus capex CN¥30.01 Million) represents 0% of total liabilities (CN¥1.24 Billion). Also explore Zhejiang Xianju Pharmaceutical Co Ltd (002332) net asset momentum to track the company's year-over-year net asset growth rate.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Zhejiang Xianju Pharmaceutical Co Ltd Financial Flexibility Index (2006–2025)
Historical Financial Flexibility Index trend for Zhejiang Xianju Pharmaceutical Co Ltd across 20 annual periods. Check 002332 strategic asset allocation to assess the company's strategic physical and investment asset allocation.
Annual Financial Flexibility Index for Zhejiang Xianju Pharmaceutical Co Ltd (2006–2025)
Year-by-year free cash flow to debt coverage for Zhejiang Xianju Pharmaceutical Co Ltd. For the full company profile including market capitalisation, see 002332 market cap overview.
| Year | Flexibility Index | Free Cash Flow (CNY) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2025 | 0.39x | CN¥456.55 Million | CN¥247.48 Million | CN¥1.18 Billion | ▼ -28.9% |
| 2024 | 0.55x | CN¥606.24 Million | CN¥398.66 Million | CN¥1.11 Billion | ▼ -23.6% |
| 2023 | 0.71x | CN¥830.11 Million | CN¥595.48 Million | CN¥1.16 Billion | ▼ -1.5% |
| 2022 | 0.72x | CN¥891.83 Million | CN¥609.28 Million | CN¥1.23 Billion | ▲ +36.7% |
| 2021 | 0.53x | CN¥942.99 Million | CN¥676.15 Million | CN¥1.78 Billion | ▲ +31.8% |
| 2020 | 0.40x | CN¥907.41 Million | CN¥789.23 Million | CN¥2.26 Billion | ▲ +42.2% |
| 2019 | 0.28x | CN¥782.15 Million | CN¥519.81 Million | CN¥2.77 Billion | ▲ +113.2% |
| 2018 | 0.13x | CN¥362.52 Million | CN¥193.27 Million | CN¥2.73 Billion | ▲ +25.4% |
| 2017 | 0.11x | CN¥290.75 Million | CN¥167.47 Million | CN¥2.75 Billion | ▼ -42.1% |
| 2016 | 0.18x | CN¥253.01 Million | CN¥155.91 Million | CN¥1.38 Billion | ▼ -25.2% |
| 2015 | 0.24x | CN¥314.65 Million | CN¥199.61 Million | CN¥1.29 Billion | ▲ +54.1% |
| 2014 | 0.16x | CN¥249.89 Million | CN¥141.64 Million | CN¥1.57 Billion | ▼ -1.3% |
| 2013 | 0.16x | CN¥252.72 Million | CN¥63.46 Million | CN¥1.57 Billion | ▼ -39.8% |
| 2012 | 0.27x | CN¥331.44 Million | CN¥33.43 Million | CN¥1.24 Billion | ▼ -45.5% |
| 2011 | 0.49x | CN¥421.77 Million | CN¥147.63 Million | CN¥860.02 Million | ▲ +57.9% |
| 2010 | 0.31x | CN¥217.87 Million | CN¥155.29 Million | CN¥701.29 Million | ▲ +63.8% |
| 2009 | 0.19x | CN¥147.62 Million | CN¥104.68 Million | CN¥778.28 Million | ▲ +48.8% |
| 2008 | 0.13x | CN¥95.28 Million | CN¥36.03 Million | CN¥747.44 Million | ▼ -49.9% |
| 2007 | 0.25x | CN¥164.08 Million | CN¥96.53 Million | CN¥644.44 Million | ▲ +68.7% |
| 2006 | 0.15x | CN¥89.56 Million | CN¥53.05 Million | CN¥593.35 Million | — |